DERM

About Journey Medical Corporation Common Stock (DERM) Stock

Journey Medical Corporation Common Stock (DERM) closed the 2026-09-17 session at $7.36, up 0.96% versus the previous close (+0.07). The stock opened at $7.53 and traded between $7.33 and $7.66 during that session. Session trading volume was 116K shares. The volume-weighted average price (VWAP) is $7.51.

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Journey Medical Corporation Common Stock has a market capitalization of $205.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. DERM is listed on the XNAS exchange. The company employs approximately 58 people. Journey Medical Corporation Common Stock is headquartered in SCOTTSDALE, AZ. The recorded listing date is 2021-11-12.

On this page you can find market DERM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.